"The contract is a cost-plus monthly reimbursement arrangement. PolyNovo will continue to contribute to the trial through the provision of product, employee resources and infrastructure support." so, the way I read it, they are incurring a small loss on products supplied to BARDA. Well worth it in the long run assuming it's a success though.
Ann: BARDA increases funding US$10M, page-62
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.35 |
Change
0.010(0.43%) |
Mkt cap ! $1.622B | |||
| Open | High | Low | Value | Volume |
| $2.32 | $2.36 | $2.27 | $2.581M | 1.110M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 48266 | $2.34 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.35 | 17871 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.35 |
Change
0.010 ( 0.55 %) |
||||
| Open | High | Low | Volume | ||
| $2.32 | $2.36 | $2.27 | 327298 | ||
| Last updated 15.59pm 17/06/2024 ? | |||||
| PNV (ASX) Chart |
